Catalent Inc. (CTLT) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
14 SCHOOLHOUSE ROAD SOMERSET, NJ 08873 |
| State of Incorp. | DE |
| Fiscal Year End | June 30 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 9/30/2024 MRQ | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 289 | 280 | 449 | 896 | 953 | 345 | |||
| Cash and cash equivalent | 289 | 280 | 449 | 896 | 953 | 345 | |||
| Receivables | 921 | 1,002 | 1,051 | 1,012 | 838 | 716 | |||
| Inventory, net of allowances, customer advances and progress billings | 574 | 777 | 702 | 563 | 324 | 257 | |||
| Inventory | 574 | 777 | 702 | 563 | 324 | 257 | |||
| Prepaid expense | 46 | 53 | 61 | 46 | 29 | 19 | |||
| Contract with customer, asset, after allowance for credit loss | 585 | 399 | 398 | ||||||
| Disposal group, including discontinued operation | 47 | ||||||||
| Other current assets | 48 | 42 | 70 | 47 | 31 | 24 | |||
| Other undisclosed current assets | 134 | 139 | 186 | 307 | 119 | 35 | |||
| Total current assets: | 2,597 | 2,692 | 2,917 | 2,918 | 2,293 | 1,396 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 3,643 | 3,682 | 3,127 | 2,524 | 1,901 | 1,537 | |||
| Intangible assets, net (including goodwill) | 3,174 | 4,019 | 4,066 | 3,336 | 3,359 | 3,152 | |||
| Goodwill | 2,333 | 3,039 | 3,006 | 2,519 | 2,471 | 2,221 | |||
| Intangible assets, net (excluding goodwill) | 841 | 980 | 1,060 | 817 | 889 | 931 | |||
| Deferred income tax assets | 7 | ✕ | |||||||
| Other noncurrent assets | 332 | 329 | 349 | 268 | 174 | 61 | |||
| Other undisclosed noncurrent assets | 55 | 49 | 66 | 49 | 39 | ||||
| Total noncurrent assets: | 7,156 | 8,085 | 7,591 | 6,194 | 5,484 | 4,788 | |||
| TOTAL ASSETS: | 9,753 | 10,777 | 10,508 | 9,112 | 7,777 | 6,184 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 983 | 994 | 1,067 | 1,121 | 820 | 594 | |||
| Accounts payable | 361 | 424 | 421 | 385 | 321 | 256 | |||
| Accrued liabilities | 622 | 570 | 646 | 736 | 499 | 338 | |||
| Debt | 48 | 536 | 31 | 75 | 73 | 77 | |||
| Total current liabilities: | 1,031 | 1,530 | 1,098 | 1,196 | 893 | 671 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 4,857 | 4,313 | 4,171 | 3,166 | 2,945 | 2,883 | |||
| Finance lease, liability | 312 | 323 | 217 | 178 | 128 | ✕ | |||
| Other undisclosed long-term debt and lease obligation | 4,545 | 3,990 | 3,954 | 2,915 | 2,729 | 2,883 | |||
| Liabilities, other than long-term debt | 261 | 302 | 352 | 312 | 339 | 268 | |||
| Deferred income tax liabilities | 5 | ✕ | |||||||
| Liability, pension and other postretirement and postemployment benefits | 95 | 100 | 103 | 137 | 135 | 144 | |||
| Other liabilities | 161 | 147 | 164 | 175 | 204 | 124 | |||
| Operating lease, liability | 55 | 85 | 73 | 88 | ✕ | ||||
| Other undisclosed noncurrent liabilities | 21 | 112 | 164 | 94 | 74 | ||||
| Total noncurrent liabilities: | 5,118 | 4,636 | 4,635 | 3,642 | 3,378 | 3,225 | |||
| Total liabilities: | 6,149 | 6,166 | 5,733 | 4,838 | 4,271 | 3,896 | |||
| Temporary equity, including noncontrolling interest | 359 | 607 | |||||||
| Equity | |||||||||
| Equity, attributable to parent, including: | 3,604 | 4,611 | 4,775 | 3,915 | 2,899 | 1,682 | |||
| Preferred stock | 0 | 0 | |||||||
| Additional paid in capital | 4,787 | 4,701 | 4,649 | 4,205 | 3,819 | 2,757 | |||
| Accumulated other comprehensive loss | (404) | (354) | (394) | (317) | (386) | (354) | |||
| Retained earnings (accumulated deficit) | (781) | 262 | 518 | 25 | (535) | (723) | |||
| Other undisclosed equity, attributable to parent | 2 | 2 | 2 | 2 | 2 | 1 | |||
| Total equity: | 3,604 | 4,611 | 4,775 | 3,915 | 2,899 | 1,682 | |||
| Other undisclosed liabilities and equity | 607 | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 9,753 | 10,777 | 10,508 | 9,112 | 7,777 | 6,184 | |||
Income Statement (P&L) ($ in millions)
| 9/30/2024 TTM | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 4,381 | 4,263 | 4,802 | 3,998 | 3,094 | 2,518 | ||
| Cost of revenue (Cost of Product and Service Sold) | (3,428) | (3,223) | (3,188) | (2,646) | (2,111) | (1,713) | ||
| Gross profit: | 953 | 1,040 | 1,614 | 1,352 | 983 | 805 | ||
| Operating expenses | (1,015) | (993) | (885) | (706) | (583) | (526) | ||
| Other undisclosed operating income (loss) | (687) | (210) | 1 | 182 | (6) | (5) | ||
| Operating income (loss): | (749) | (163) | 730 | 828 | 394 | 274 | ||
| Nonoperating income (expense) | 24 | 7 | (28) | (3) | (8) | (3) | ||
| Investment income, nonoperating | (10) | 179 | 6 | 8 | ||||
| Gain (loss), foreign currency transaction, before tax | (13) | 9 | (30) | 4 | (2) | 1 | ||
| Other nonoperating income (expense) | (4) | (1) | (4) | 20 | 5 | 13 | ||
| Interest and debt expense | (21) | 3 | 3 | 3 | (6) | (4) | ||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (113) | (120) | (107) | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (746) | (153) | 705 | 715 | 260 | 160 | ||
| Other undisclosed loss from continuing operations before income taxes | (281) | (189) | (126) | |||||
| Income (loss) from continuing operations before income taxes: | (1,027) | (342) | 579 | 715 | 260 | 160 | ||
| Income tax expense (benefit) | (16) | 86 | (80) | (130) | (40) | (23) | ||
| Income (loss) from continuing operations: | (1,043) | (256) | 499 | 585 | 221 | 137 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 585 | 221 | 137 | |
| Net income (loss) attributable to parent: | (1,043) | (256) | 499 | 585 | 221 | 137 | ||
| Other undisclosed net loss available to common stockholders, basic | (16) | (56) | (48) | (5) | ||||
| Net income (loss) available to common stockholders, diluted: | (1,043) | (256) | 483 | 529 | 173 | 132 | ||
Comprehensive Income ($ in millions)
| 9/30/2024 TTM | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (1,043) | (256) | 499 | 585 | 221 | 137 | ||
| Other comprehensive income (loss) | (50) | 40 | (77) | 69 | (32) | (28) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (1,093) | (216) | 422 | 654 | 188 | 109 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.